p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage

Myriam Cuadrado1, Paula Gutierrez-Martinez, Aneta Swat

  • 1Genomic Instability Group, Spanish National Cancer Research Centre, Madrid, Spain.

Cancer Research
|October 22, 2009
PubMed

Insights

This study reveals a new DNA damage response pathway involving p27Kip1 and retinoblastoma proteins, crucial for maintaining cell cycle arrest after prolonged DNA damage. This pathway is independent of canonical DDR but downstream of p38 MAPK.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The oncogene-induced DNA damage (DDR) model suggests early-stage tumor growth is limited by DNA damage responses.
  • Understanding cellular responses to persistent DNA damage is crucial, contrasting with studies on acute genotoxic insults.

Purpose of the Study:

  • To discover and characterize a novel DNA damage-responsive pathway activated by persistent genotoxic exposure.
  • To investigate the role of this pathway in cell cycle arrest maintenance.

Main Methods:

  • Investigated cellular responses to persistent clastogen exposure.
  • Utilized molecular biology techniques to identify key pathway components (p27Kip1, retinoblastoma tumor suppressors).
  • Assessed the pathway's dependence on canonical DDR pathways (ATM, ATR) and its relation to p38 MAPK.

Main Results:

  • Discovered a novel pathway involving p27Kip1 and retinoblastoma tumor suppressors, activated by persistent clastogen exposure.
  • This pathway is critical for maintaining, but not initiating, DNA damage-induced cell cycle arrest.
  • The identified pathway is independent of ATM/ATR-dependent DDR and acts downstream of p38 MAPK.

Conclusions:

  • A novel, late-acting DNA damage response pathway has been identified.
  • This pathway plays a key role in sustaining cell cycle arrest under persistent DNA damage conditions.
  • Findings may help reconcile the oncogene-induced DNA damage model with the importance of non-DDR tumor suppressors in human cancer.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...